Your browser doesn't support javascript.
loading
Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond.
Simões, Daniel; Ehsani, Soudeh; Stanojevic, Maja; Shubladze, Natalia; Kalmambetova, Gulmira; Paredes, Roger; Cirillo, Daniela Maria; Avellon, Ana; Felker, Irina; Maurer, Florian P; Yedilbayev, Askar; Drobniewski, Francis; Vojnov, Lara; Johansen, Anne S; Seguy, Nicole; Dara, Masoud.
Afiliação
  • Simões D; Instituto de Saúde Pública - Universidade do Porto, Porto, Portugal.
  • Ehsani S; Member of the European Laboratory Initiative on TB, HIV and Viral Hepatitis (ELI) core group. The additional members of the ELI core group are listed under Acknowledgements.
  • Stanojevic M; WHO Regional Office for Europe, Copenhagen, Denmark.
  • Shubladze N; Member of the European Laboratory Initiative on TB, HIV and Viral Hepatitis (ELI) core group. The additional members of the ELI core group are listed under Acknowledgements.
  • Kalmambetova G; Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Paredes R; Member of the European Laboratory Initiative on TB, HIV and Viral Hepatitis (ELI) core group. The additional members of the ELI core group are listed under Acknowledgements.
  • Cirillo DM; National Reference Laboratory, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
  • Avellon A; Member of the European Laboratory Initiative on TB, HIV and Viral Hepatitis (ELI) core group. The additional members of the ELI core group are listed under Acknowledgements.
  • Felker I; National TB Reference Laboratory, Bishkek, Kyrgyzstan.
  • Maurer FP; Member of the European Laboratory Initiative on TB, HIV and Viral Hepatitis (ELI) core group. The additional members of the ELI core group are listed under Acknowledgements.
  • Yedilbayev A; Infectious Diseases Department & irsiCaixa AIDS Research Institute, Badalona, Catalonia, Spain.
  • Drobniewski F; Member of the European Laboratory Initiative on TB, HIV and Viral Hepatitis (ELI) core group. The additional members of the ELI core group are listed under Acknowledgements.
  • Vojnov L; IRCCS San Raffaele Scientific Institute, Milan Italy.
  • Johansen AS; Member of the European Laboratory Initiative on TB, HIV and Viral Hepatitis (ELI) core group. The additional members of the ELI core group are listed under Acknowledgements.
  • Seguy N; Hepatitis Unit, National Center of Microbiology, Instituto de Salud Carlos III, CIBERESP, Madrid, Spain.
  • Dara M; Novosibirsk Tuberculosis Research Institute, Novosibirsk, Russia.
Euro Surveill ; 27(29)2022 07.
Article em En | MEDLINE | ID: mdl-35866437
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Infecções Sexualmente Transmissíveis / Infecções por HIV / Hepatite C / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Portugal
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Infecções Sexualmente Transmissíveis / Infecções por HIV / Hepatite C / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Portugal